KEWAUNEE SCIENTIFIC CORP /DE/(KEQU)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,392 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
KEQU Stock Analysis & AI Quality Score
AI stock analysis and institutional research for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU), a Technology sector company. 13F Pro's AI-powered ranking engine scores KEQU at 51.4/100 on a 32-signal composite quality model, placing it at rank #1,392 of 2,879 stocks — the top half of the AI-ranked universe. KEQU scores in the top quartile across revenue growth (83.6). Areas of concern include earnings quality (22.7) and revenue scale (28.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q4 2026), KEWAUNEE SCIENTIFIC CORP /DE/ reports quarterly revenue of $71.4M, net income of $3.4M, an operating margin of 7.3%. Top institutional holders of KEQU by reported 13-F value include NORTHERN, DIMENSIONAL FUND ADVISORS, Minerva Advisors, based on the most recent SEC filings. KEQU trades on the Nasdaq exchange and files with the SEC under CIK 55529. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KEQU daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for KEWAUNEE SCIENTIFIC CORP /DE/ directly from SEC EDGAR. KEWAUNEE SCIENTIFIC CORP /DE/'s 13F Pro composite quality score has ranged between 23 and 54 since 2021, currently 51.4 — an improving long-term trajectory across 28 quarterly and live scoring snapshots.
Revenue
Q4 2026
$71.4M
Net Income
Q4 2026
$3.4M
Free Cash Flow
Q4 2026
$4.5M
Operating Margin
Q4 2026
7.3%
ROIC
Q4 2026
5.5%
D/E Ratio
Q4 2026
0.34
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+28.5% YoYNet Income
+1203.3% YoYOperating Income
+211.6% YoYEPS (Diluted)
+1188.0% YoYTotal Assets
+50.0% YoYTotal Debt
+601.3% YoYOp. Cash Flow
+591.6% YoY| Metric | FY 2026 | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue | $282.0M +28.5% | $219.5M +30.0% | $168.9M +14.5% | $147.5M +0.6% | $146.6M -7.3% | $158.1M |
| Net Income | $9.6M +1203.3% | $738.0K +112.0% | $-6.1M -66.8% | $-3.7M -340.2% | $1.5M -71.0% | $5.3M |
| Operating Income | $16.7M +211.6% | $5.4M +305.7% | $-2.6M -98.2% | $-1.3M -162.3% | $2.1M -78.7% | $9.9M |
| EPS (Diluted) | $3.22 +1188.0% | $0.25 +111.4% | $-2.20 -65.4% | $-1.33 -341.8% | $0.55 -71.1% | $1.90 |
| Total Assets | $178.3M +50.0% | $118.9M +0.1% | $118.8M +32.9% | $89.4M +2.5% | $87.2M +2.5% | $85.1M |
| Total Debt | $25.2M +601.3% | $3.6M +125.9% | $1.6M -76.7% | $6.8M +164.7% | $2.6M -28.3% | $3.6M |
| Operating Cash Flow | $18.6M +591.6% | $-3.8M +51.9% | $-7.9M -964.6% | $912.0K -63.4% | $2.5M -21.8% | $3.2M |
AI Insight: KEQU Financial Trends
Revenue stabilized near $70M after post-acquisition spike, but operating margins remain compressed and cash generation is lumpy.
• Operating margin fell from 8.3% in Q2 2025 to 7.0% in Q2 2026, indicating persistent margin pressure despite revenue stability.
• Total debt declined from $42M in Q2 2025 to $25M in Q2 2026, reducing leverage and improving balance sheet strength.
• Operating cash flow swung from +$9M in Q2 2025 to +$5M in Q2 2026, reflecting inconsistent working capital management.
⚠ Revenue declined 8% from Q2 2025 peak ($77M) to Q2 2026 ($71M); sustaining current level critical given margin sensitivity.
⚠ Net income remains volatile and low (≤$5M quarterly); operating leverage not yet materializing post-acquisition integration.
⚠ Operating cash flow unpredictability (swings from -$4M to +$12M) masks underlying operational efficiency gains from deleveraging.
AI Insight: KEQU Ratio Trends
Kewaunee swung from Q1 2026 collapse (NPM 1.0%, ROE 3.9%) to Q2 2026 recovery (NPM 4.8%, ROE 18.1%), but profitability remains below pre-2025 peaks.
• Operating margin rebounded to 7.3% in Q2 2026 from 3.7% in Q1 2026, yet trails Q2 2025's 11.0% and Q4 2024's 9.3%.
• Leverage improved; D/E fell to 0.34 in Q2 2026 from 0.67 in Q1 2025, lowest in the series.
• ROIC recovered to 20.9% in Q2 2026 from 10.7% in Q1 2026, but below Q2 2025's 32.0% peak.
⚠ Q1 2026 profitability crater (NPM 1.0%, ROE 3.9%, ROA 1.6%) signals seasonal or operational stress; sustainability unclear.
⚠ Volatility persists: OpMargin ranges 3.4–11.0% over last four quarters; no stable trend established.
Get alerted when KEQU's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for KEWAUNEE SCIENTIFIC CORP /DE/ including:
Top Institutional Holders of KEQU
NORTHERN TRUST CORP
$8.4M245,964 shDIMENSIONAL FUND ADVISORS LP
$6.1M177,339 shMinerva Advisors LLC
$4.7M136,705 shVANGUARD CAPITAL MANAGEMENT LLC
$3.9M112,513 shPUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
$3.5M100,702 shRENAISSANCE TECHNOLOGIES LLC
$3.4M98,511 shDe Lisle Partners LLP
$1.8M52,626 shAMERICAN CENTURY COMPANIES INC
$1.7M49,551 shROYCE & ASSOCIATES LP
$1.6M48,000 shGEODE CAPITAL MANAGEMENT, LLC
$839.1K24,479 sh
| Fund | Value | Shares |
|---|---|---|
| NORTHERN TRUST CORP | $8.4M | 245,964 |
| DIMENSIONAL FUND ADVISORS LP | $6.1M | 177,339 |
| Minerva Advisors LLC | $4.7M | 136,705 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.9M | 112,513 |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | $3.5M | 100,702 |
| RENAISSANCE TECHNOLOGIES LLC | $3.4M | 98,511 |
| De Lisle Partners LLP | $1.8M | 52,626 |
| AMERICAN CENTURY COMPANIES INC | $1.7M | 49,551 |
| ROYCE & ASSOCIATES LP | $1.6M | 48,000 |
| GEODE CAPITAL MANAGEMENT, LLC | $839.1K | 24,479 |
More Technology Companies
View all Technology →Put KEQU on your watchlist
Track score changes the day KEWAUNEE SCIENTIFIC CORP /DE/ files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is KEQU a good stock to buy?
13F Pro's AI-powered analysis of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for KEQU are available on the KEQU stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own KEQU?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling KEQU. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of KEWAUNEE SCIENTIFIC CORP /DE/'s investment landscape.